We serve Chemical Name:(1-methylpyrrol-2-yl)methanol CAS:52160-51-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(1-methylpyrrol-2-yl)methanol
CAS.NO:52160-51-7
Synonyms:N-methyl-2-hydroxymethylpyrrole;2-Hydroxymethyl-1-methylpyrrole;2-Pyrrolemethanol,1-methyl;1H-Pyrrole-2-methanol,1-methyl
Molecular Formula:C6H9NO
Molecular Weight:111.14200
HS Code:2933990090
Physical and Chemical Properties:
Melting point:28ºC
Boiling point:219.5ºC at 760 mmHg
Density:1.03g/cm3
Index of Refraction:1.512
PSA:25.16000
Exact Mass:111.06800
LogP:0.51740
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-methyl-2-hydroxymethylpyrrole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrrole-2-methanol,1-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Hydroxymethyl-1-methylpyrrole Use and application,2-Pyrrolemethanol,1-methyl technical grade,usp/ep/jp grade.
Related News: With rising demand and approvals required for new drugs, an external collaboration with CDMOs helps in driving a successful and robust clinical development plan for a new drug molecule. 1,2,3,6-Tetrahydro-3-[[1-(phenylsulfonyl)-1H-indol-2-yl]carbonyl]pyridine-1-acetic acid ethyl ester manufacturers Stevanato’s been out of start-up mode for a while: The firm doubled its net profit to $94 million in 2020 on $779 million in revenues, which were up 23% from 2019. That strong growth in sales helped place Sergio Stevanato, 79, Giovanni’s son and the company’s chairman emeritus, on Forbes’ World’s Billionaires list for the first time in 2021, with a net worth of $1.9 billion. 6,7-dichloro-5-(4-(2-hydroxyethyl)-4H-1,2,4-triazol-3-yl)-1,4-dihydroquinoxaline-2,3-dione suppliers Mindset Pharma Inc. is a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet needs. 1-N,1-N-diethyl-4-N-quinazolin-4-ylpentane-1,4-diamine,phosphoric acid vendor & factory.
